标题
Endothelin Receptor Antagonists in Kidney Disease
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 4, Pages 3427
出版商
MDPI AG
发表日期
2023-02-09
DOI
10.3390/ijms24043427
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Lack of renoprotective effects of targeting the endothelin A receptor and/or sodium glucose transporter 2 in a mouse model of type 2 diabetic kidney disease
- (2022) Deborah C Stuart et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease
- (2022) Yang Yang et al. Frontiers in Endocrinology
- Novel Therapies for Alport Syndrome
- (2022) Efren Chavez et al. Frontiers in Medicine
- Enhanced Cardiorenal Protective Effects of Combining SGLT2 Inhibition, Endothelin Receptor Antagonism and RAS Blockade in Type 2 Diabetic Mice
- (2022) Ander Vergara et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
- (2022) Markus P Schlaich et al. LANCET
- Comparative assessment of efficacy and safety of ambrisentan and bosentan in patients with pulmonary arterial hypertension: A meta‐analysis
- (2021) Qinhua Zhao et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Effects of systemic and renal intramedullary endothelin-1 receptor blockade on tissue NO and intrarenal hemodynamics in normotensive and hypertensive rats
- (2021) Bożena Bądzyńska et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- NCATS Inxight Drugs: a comprehensive and curated portal for translational research
- (2021) Vishal B Siramshetty et al. NUCLEIC ACIDS RESEARCH
- Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects
- (2020) Matthew Griffin et al. CIRCULATION
- Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
- (2020) Frederik C. Enevoldsen et al. Journal of Clinical Medicine
- Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: A systematic review and meta‐analysis of randomized controlled trials
- (2020) Y. Zhou et al. DIABETIC MEDICINE
- New insights from SONAR indicate adding sodium glucose co-transporter 2 inhibitors to an endothelin receptor antagonist mitigates fluid retention and enhances albuminuria reduction
- (2020) Hiddo J.L. Heerspink et al. KIDNEY INTERNATIONAL
- Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study
- (2020) Edouard L. Fu et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Single- and multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the dual endothelin receptor antagonist aprocitentan in healthy adult and elderly subjects
- (2019) Patricia Sidharta et al. Drug Design Development and Therapy
- Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials
- (2019) Eikan Mishima et al. HYPERTENSION RESEARCH
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- (2019) Hiddo J L Heerspink et al. LANCET
- Bosentan for Treatment of Pediatric Idiopathic Pulmonary Arterial Hypertension: State-of-the-Art
- (2019) Yuchen Wang et al. Frontiers in Pediatrics
- Selective ETA vs. dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats
- (2019) Katrina M Mirabito Colafella et al. CARDIOVASCULAR RESEARCH
- Effect of Multiple-Dose Aprocitentan Administration on the Pharmacokinetics of Midazolam in Healthy Male Subjects
- (2019) Patricia N. Sidharta et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Endothelin: 30 Years From Discovery to Therapy
- (2019) Matthias Barton et al. HYPERTENSION
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
- (2018) Howard Trachtman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment
- (2017) Lennart Tonneijck et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Endothelin A receptor blocker and calcimimetic in the adenine rat model of chronic renal insufficiency
- (2017) Suvi Törmänen et al. BMC Nephrology
- Ambrisentan: a review of its use in pulmonary arterial hypertension
- (2017) Belinda N. Rivera-Lebron et al. Therapeutic Advances in Respiratory Disease
- Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials
- (2016) Xinfang Xie et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism
- (2016) Taylor W. Harvey et al. AMERICAN JOURNAL OF NEPHROLOGY
- Pharmacokinetic and pharmacodynamic evaluation of macitentan, a novel endothelin receptor antagonist for the treatment of pulmonary arterial hypertension
- (2015) Patricia N Sidharta et al. Expert Opinion on Drug Metabolism & Toxicology
- Endothelin Receptors and Their Antagonists
- (2015) Janet J. Maguire et al. SEMINARS IN NEPHROLOGY
- Endothelin Blockade in Diabetic Kidney Disease
- (2015) Lidia Anguiano et al. Journal of Clinical Medicine
- The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
- (2014) D. de Zeeuw et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Endothelin and endothelin antagonists in chronic kidney disease
- (2014) Donald E Kohan et al. KIDNEY INTERNATIONAL
- Macitentan: First Global Approval
- (2013) Trina Patel et al. DRUGS
- Addition of ETA receptor blockade increases renoprotection provided by renin–angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats
- (2013) Věra Čertíková Chábová et al. LIFE SCIENCES
- Glomerular hyperfiltration: definitions, mechanisms and clinical implications
- (2012) Imed Helal et al. Nature Reviews Nephrology
- Selective Endothelin-A Receptor Antagonism Reduces Proteinuria, Blood Pressure, and Arterial Stiffness in Chronic Proteinuric Kidney Disease
- (2011) Neeraj Dhaun et al. HYPERTENSION
- Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy
- (2011) D. E. Kohan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Darusentan is a potent inhibitor of endothelin signaling and function in both large and small arteriesThis article is one of a selection of papers published in the two-part special issue entitled 20 Years of Endothelin Research.
- (2010) Faquan Liang et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes
- (2010) M. A. Saleh et al. DIABETOLOGIA
- Endothelin-1 Increases Glomerular Permeability and Inflammation Independent of Blood Pressure in the Rat
- (2010) Mohamed A. Saleh et al. HYPERTENSION
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Endothelin type A and B receptors in the control of afferent and efferent arterioles in mice
- (2010) Janice Schildroth et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria
- (2009) R. R. Wenzel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
- (2009) Michael A Weber et al. LANCET
- INHALED TEZOSENTAN REDUCES PULMONARY HYPERTENSION IN ENDOTOXIN-INDUCED LUNG INJURY
- (2009) Björn P. Persson et al. SHOCK
- Endothelin: 20 years from discovery to therapyThis article is one of a selection of papers published in the special issue (part 2 of 2) on Forefronts in Endothelin.
- (2008) Matthias Barton et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist
- (2008) M. Iglarz et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now